Author: lvc-admin

Categories
Global stocks Shares

Woolworths Ltd (WOW) posted solid FY21 results along with off-market buy-back

Investment Thesis :

  • Leading market positions with strategic locations in areas with strong population growth.
  • Positively correlated with population growth throughout time.
  • Increasing digitalization to save costs and improve the supply chain’s efficiency.
  • For the core Australian Food segment, key leading indicators (such as basket size / goods per basket) are improving.
  • Customer metrics and transaction growth are both improving. 
  • The momentum of BIG W is expected to continue.
  • Capital management post Endeavour deal.

Key Risks:

  • The Food & Petrol business is seeing more margin pressure.
  •  Changing consumer preferences and purchasing trends, as well as increased retail competition.
  • Deterioration in balance sheet as a result of lower earnings.
  • Unfavourable fluctuation in AUD/USD (international sourcing).

Key highlights of FY 2021: 

Following the demerger of Endeavour Drinks, Woolworths Ltd (WOW) posted solid FY21 results and a $2 billion off-market buy-back. Relative to pcp:

  •  During the year Woolworth reported sales of $67,278 million were up 5.7 percent (online sales of $5,602 million were up 58.1 percent).
  • The  revenue of Woolworth  is from following segment (1)  Australian Food (2) ) New Zealand Food (3) ) New Zealand Food (4)  Discontinued operations.
  • In the year 2021 , 80%of  sales revenue of Woolworths (continuing operation )was from Australia amounting to $44,441m , 12% of sales revenue was from  new zealand zone amounting to $6,652,8% of revenue from BIG W amounting to $4,583 and  sales from discontinued operation “Endeavour Drinks” amounted $10167.
  • During the year, the firms EBIT was $3,663m, up by 13.7% EBIT from continuing operations  was $2,764m, up by 11.1% driven by a 9% increase from Australian Food and an increase of over 300% from BIG W.
  • Group EBIT margin was 5%, up by 28bps.
  • Cost of doing business increased 16bps due to higher CODB in NZ and higher contribution from Big, which operates on a higher CODB.
  • NPAT of $1,972m, up by 22.9%.
  • The Board declared a final dividend of 55cps which brings FY21 dividend to 108cps, up by 14.9%. Shareholders on the record date of 3 September 2021 are eligible for the final dividend of $0.55

$2bn off-market buy-back: WOW announced $2bn capital return via an off-market buy-back. The Buy-Back will be handled through a tender process. . Eligible Shareholders who choose to participate can offer to sell some or all of their Shares to WOW at:  (1) a discount to the Market Price of 10% to 14% (inclusive) at 1% intervals; or (2) the Buy-Back Price established by WOW after the tender process is completed (as a Final Price Offer). (1) a discount to the Market Price of 10% to 14% (inclusive) at 1% intervals; or (2) the Buy-Back Price (1) a discount to the Market Price of 10% to 14% (inclusive) at 1% intervals; or (2) the Buy-Back Price, established by WOW. The Buy-Back Price will be determined as the lowest price at which WOW can buy back the targeted amount of capital.

The buyback period begins on September 13 and ends on October 15, 2021. On October 21, 2021, the Buy-Back Price will be paid to successful Eligible Shareholders.

Shareholders benefits from buyback: The Buy-Back Price paid for each share purchased back will be $4.31, with the remaining being a fully franked dividend. The Buy-Back Price may be lower than the price at which one might sell their shares on ASX, but  after-tax return may be greater because of personal tax status and the tax treatment of the Capital Component, dividend Component, and franking credits.

Company Profile:

Woolworths Limited (WOW) is an Australian retailer that operates supermarkets, speciality and discount department shops, as well as liquor and electronics stores. Woolworths also produces processed foods, exports and wholesales food, and sells gasoline. The corporation also owns and runs hotels that feature pubs, restaurants, lodging, and gambling.

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
Technology Stocks

Pro Medicus reports strong FY21 results beating market estimates

Investment Thesis:

  • Management believes they are 24 months ahead of their competitors driven by proven and market leading technology, thereby making PME’s product command a price premium. 
  • New contract wins by Pro Medicus (more win rates plus higher value per contract) and increase in usage by existing clients. 
  • Launch of new products namely; Enterprise imaging solutions, exploring other “ologies” such as cardiology and ophthalmology. 
  • Development of artificial intelligence (AI) capabilities. 
  • Leveraged to the digital health data thematic and industry’s transition to cloud. 
  • Business expansion into new geographies.
  • Probability of Mergers and Acquisitions.

Key Risks:

  • Stock price exposed to more volatility on account of high valuation.
  • Long lead time to close contracts and scalability of new contract leads to disappointment with reference to market anticipations. 
  • Renewal of contracts (pricing pressure) and potential budget reduction at hospitals leads to the delay of software upgrades / investment. 
  • Large scale players and new entrants with innovative technology offer increase in competitive pressures. 
  • Reliability of system i.e. data breach or drop in quality. 
  • Regulatory / funding changes, for instance, reimbursement changes leading to lower imaging volumes.

Key Highlights:

  • PME to benefit from their recent contract wins and is positively leveraged to several important themes – digital health data, replacing legacy technology with PME’s innovative platform, AI adoption in imaging, Electronic Health Records (EHR) driving PME’s Enterprise Imaging solutions and PME’s cloud solution substantially increasing its concerned market.
  • Pro Medicus Ltd (PME) reported solid FY21 results outperforming the market estimates. The profit before tax of $42.6m, was up +41.0% mainly because of significant revenue growth in three key jurisdictions – North America, up +18.0%, Australia, up +23.4% and Europe, up +25.7%.
  • Revenue of $67.9m is up by 19.5% 
  • Underlying profit before tax $42.6m, which is up by 41.0%  
  • Net profit of $30.9m is up by 33.7%. 
  • PME remains debt-free with cash reserves at year-end of $61.8m, 42.4% higher than pcp. 
  • The Board declared a fully franked final dividend of 8c per share, which brings the total FY21 dividend to 15cps.
  • In FY21, PME won key contracts which are as follows: (1) NYU Langone (A$25.0m, 7-year) (2) Zwanger-Pesiri (A$8.5m, 5-year renewal) (3) LMU Klinikum (A$10.0m, 7-year) (4) Medstar Health (A$18.0m, 5-year) (5) Intermountain Healthcare (A$40.0m, 7-year) (6) University of California (A$31.0m, 7-year) (7) University of Vermont (A$14.0m, 8-year)

Company Profile:

Pro Medicus Ltd (PME) was founded in 1983 and provides a full range of radiology IT software and services to hospitals, imaging centers and health care groups globally. In Jan-09, PME purchased Visage Imaging, which has become a global provider of leading-edge enterprise imaging solutions, pioneering the best-of-breed, or Deconstructed PACSSM enterprise imaging strategy. Visage 7 technology delivers fast, multi-dimensional images streamed via an intelligent thin-client viewer. The company offers a leading suite of RIS, PACS and e-health solutions constituting one of the most comprehensive end-to-end offerings in radiology. Pro Medicus has global offices in Melbourne, Berlin (R&D) and San Diego (Sales).

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
Commodities Trading Ideas & Charts

Australian Pipeline to offer a whopping dividend of 6%

Investment Thesis

  • Difficult part to replicate is high quality assets.
  • Attractive and Growing distribution yield.
  • Highly credit worthy customers.
  • Currently, the US focuses on assessing international opportunities.
  • Growth through acquisitions.
  • Customers are diversified by sectors.
  • Largest owner of gas transmission pipelines in Australia.
  • Opportunity to grow its renewable business.
  • Management announced their ambition to achieve net zero operations emissions by 2050.

Key Risks

  • Negative market/investor sentiment toward “bond proxies.”
  • Pipeline regulators may make future regulatory changes.
  • The energy sector affects a large number of businesses.
  • Issues with infrastructure, such as explosions or ruptures.
  • COAG’s adverse decision examines transmission costs.
  • Contract terms on existing capacity are being shortened.

FY21 Result Summary

  • Revenue (excluding pass-through) increased +0.7% year on year to $2,144.5m, boosted in part by a partial year contribution from the Orbost Gas Processing Plant.
  • Underlying EBITDA decreases -1.3% over pcp to $1,633million, due to increased investment in strategic development opportunities and capability, higher insurance and compliance cost and softer contract renewals in challenging market conditions.
  • NPAT (excluding significant items) was down -9.6% to $281.8m due to the lower EBITDA and higher depreciation costs from growing asset base. Reported NPAT was $3.7m, impacted by the $249.3m non-cash Orbost impairment charge and $148m in finance costs associated with bond note redemptions.
  • Total capex increased +3.3 percent year on year to $432.5 million (growth capex decreased -1.5 percent to $283.5 million and stay-in-business capex increased +23 percent to $134.6 million), with management expecting organic growth capex to exceed $1.3 billion over FY22-24, up from $1 billion in 1H21.
  • Free Cash Flow of $901.9 million was down -5.7 percent year on year, owing primarily to a one-time distribution and interest earned by APA from its investments in SEA Gas in FY20. Approximately, 6% dividend is offered by Australian Pipeline Trust Group.

Company Profile 

APA Group Limited (APA) is a natural gas infrastructure company. The Company owns and/or operates gas transmission and distribution assets whose pipelines span every state and territory in mainland Australia. APA Group also holds minority interests in energy infrastructure enterprises. APA derives its revenue through a mix of regulated revenue, long-term negotiated contracts, asset management fees and investment earnings.

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
Technology Stocks

Sonic Healthcare increased its margins in both its laboratory and imaging divisions

Investment Thesis

  • Ageing Population Requires more diagnostic tests especially as medicine focuses on Preventives medicine
  • Market leading positions in Pathology(number one in Australia, Germany, Switzerland and United Kingdom number three in US). Australia is the Second leading player in the market in Imaging. 
  • Establishment of Global Channels to high barriers entry.
  • Organic growth and potential improvement from margin cost strategy on the acquisition of ongoing bolt.
  • Leveraged against a weakening dollar.
  • Globally Diversified.

Key Risks

  • Diagnostic expenses are being decreased as a result of disruptive technology.
  • Market share is being lost due to competitive threats.
  • Deregulation has resulted in the establishment of new pathology collection centres.
  • Regulative changes that are detrimental (fee cuts).
  • Growth that has been disappointing.
  • Unfavorable currency fluctuations (AUD, EUR, USD).

FY21 results highlights 

  • Revenue Growth of +28 to A$8.8 billion. In constant Currency, revenue of $9,129 million was up +33.7%, driven by Covid-19 testing revenue in each of SHL’s laboratory businesses. Base business revenue (exclude Covid testing) grew +6% versus FY20 and +4% versus FY19.
  • EBITDA growth of +81% to A$ 2.6 Billion (or +89% on constant Currency basis) driven by +97% EBITDA Growth of +89% in the laboratory division due to Covid-19 testing. 
  • Net profit growth of +149% to A$1.3 billion, reflecting growth in revenue and SHL’s strong operating leverage. 
  • Sonic Healthcare achieved margin accretion in both laboratory and imaging divisions.
  • SHL’s balance sheet is well placed with record low gearing level and liquidity of ~A$1.5bnto fund growth via acquisitions. 
  • Gearing (Net debt/[Net debt + equity) of 12.5%, interest cover (EBITA/Net interest expense) of 33.8x and debt cover (Net debt/EBITDA) of 0.4x all improved from 21.6%, 20.5x and 1.0x, respectively, at Dec-20 (and remains within covenant limit of <55%, >3.25x, and <3.5x respectively). 
  • As per its progressive dividend policy, sonic healthcare declared a final dividend of 55cps, up +8% and franked to 65%. Total dividends are up +7%.

Company Profile 

Sonic Healthcare (SHL) is a medical diagnostics company with operations in Australia, New Zealand, and Europe. The company provides a comprehensive range of pathology and diagnostic imaging services to medical practitioners, hospitals and their patients along with providing administrative services and facilities to medical practitioners. SHL has three main segments: (1) Pathology/clinical laboratory services based in Australia, NZ, UK, US, Germany, Switzerland, Belgium and Ireland. (2) Diagnostic imaging services in Australia; and (3) Other which includes medical centre operations (IPN), occupational health services (Sonic HealthPlus) and laboratory automation development (GLP Systems).

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
Shares Technology Stocks

Despite a rise in earnings, the share price of Nine Entertainment has dropped.

20025825 - closeup image of businessman drawing 3d graphics

Investment Thesis

  • Upside potential to NEC’s share price from investors ascribing a higher value for Stan, NEC’s subscription video of demand (SVOD). Stan is now cash flow positive and profitable, with margins having the potential to surprise on the upside. 
  • Relatively attractive dividend yield of ~4%. 
  • NEC is a now a much more diversified business, with revenue not dominated by traditional FTA TV but also attractive digital platforms and assets. 
  • Cost out strategy – looking to remove $230m in structural costs.  
  • Corporate activity given NEC’s strategic assets.
  • Trading below our valuation.

Key Risks

We see the following key risks to our investment thesis:

  • Competitive pressure in Free to Air (FTA) TV and SVOD. 
  • Stan growth (subscriber numbers or breakeven point) disappoints market expectations. 
  • Structural decline in TV audiences continues to impact sentiment towards the stock. 
  • Deterioration in advertising markets.
  • Cost blowouts in obtaining new programming/content.
  • Increased competition from Netflix and Disney.

FY21 Results Highlights. Relative to the pcp: 

  • Revenue of $2,331.5, up +8%. 
  • Group EBITDA of $564.7m, was up +43%. 
  • NPAT of $277.5m, was up +76%, which translates to fully diluted EPS of 15.3%, up +83%.
  • The Board declared a final dividend per share of 5.5cps which brings full year total dividends to 10.5cps, up +50%, and equates to a payout ratio of ~69% (in line with management’s policy of paying ~60-80% through the cycle).

Current trading environment and outlook

NEC did not provide specific quantitative FY22 earnings guidance but did provide significant colour: 

  • “Nine started the new financial year strongly, well supported across our platforms by advertisers from all categories. In the current quarter, Nine’s metro FTA ad revenue is expected to be up almost 20% on the same quarter last year. Forward bookings remain ahead of same day last year, with positive market momentum continuing into Q2, notwithstanding more difficult comparables, including timing of the NRL. The FTA ad market has recovered more quickly and convincingly than previously expected. FY22 will see the return of some cyclical costs – Nine currently expects FTA costs in FY22 to be ~3% higher than FY21”. 
  • 9Now: “continues its strong growth trajectory, with around 70% revenue growth in July (on pcp). Nine expects positive momentum to continue through the rest of FY22, as 9Now establishes its place in the broader digital video market”.
  • Nine Radio: “Notwithstanding the short-term impact of the lockdown on the radio market, Nine Radio’s Q1 ad revenues are expected to grow in the double-digits (%), with further share improvement across both agency and local ad sales. Coupled with Nine Radio’s restructured cost base, this is expected to underpin strong profit leverage as the ad market recovers”. 
  • Stan: “Total costs for Stan Sport in FY22 are now expected to be at the lower end of the $70-90m range previously cited. Whilst this investment will reduce Stan’s overall EBITDA in the short term (in FY22 combined EBITDA for Stan Entertainment and Stan Sport is expected to be in the low double-digit millions of dollars), over the medium and longer term, it is expected to significantly grow earnings”. 
  • Publishing: “As previously announced, Nine expects growth of $30-40m in Publishing EBITDA in FY22 on FY21”.

Company Description  

Nine Entertainment Co (NEC), through its subsidiaries, broadcast news and current affairs, sporting events, comedy, entertainment and lifestyle programs. Nine Entertainment serves customers throughout Australia. NEC has repositioned itself from a linear free-to-air broadcaster, to a creator and distributor of cross-platform, premium content. While the channel Nine Network remains core, it is now complemented by subscription video on demand (SVOD) provider Stan, a live streaming and catch-up service 9Now, digital network nine.com.au and array of digital content.

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
Commodities Trading Ideas & Charts

Adbri’s stock price drops but building boom raises profits

Investment Thesis

  • Macro conditions remains uncertain in key regions.
  • Strong pipeline of infrastructure projects over the next 2 years is a positive but timing and execution is a risk. 
  • Solid balance sheet position provides some flexibility to the Company to pursue growth. 
  • Leading positions as a lime producer, concrete products producer and cement and clinker supplier.
  • Outlook for lime looks relatively positive with higher infrastructure projects and resource sector activity
  • Cost-out and vertical integration (cement) programs expected to deliver cost benefits that exceed cost headwinds of $10m in FY21.

Key Risks

We see the following key risks to our investment thesis:

  • Softer sales volume than expected.
  • Loss of market share to competitors or imports and pressure on pricing. 
  • Softer than expected pricing increases.
  • Higher than expected energy prices.
  • Execution risk in relation to Company’s cost-out and vertical integration strategies.
  • Deterioration of A$ relative to other currencies.
  • Unfavorable weather impacts. 

1H21 results summary

  • Revenue was up +7.4% over pcp to $752.3m with robust demand, particularly on the eastern seaboard, driving higher volumes across all products. Lime pricing declined in accordance with contractual arrangements, while average cement price increased marginally, and concrete and aggregate prices were stable overall. 
  • Underlying EBITDA increased +8.7% over pcp to $133.1m with margins improving +20bps to 17.7%, benefitting from disciplined implementation of cost efficiencies across the Group. 
  • Underlying NPAT of $55m was up +15.5% over pcp driven by improved demand for construction materials supported by increased residential housing activity and infrastructure spending. 
  • Operating cash flow of $76.8m declined -34% over pcp, largely due to the one-off benefit in the prior year of Covid-19 stimulus measures with the temporary deferral of GST and PAYG payments that boosted 1H20 cash flow by circa $30m (measures reversed in 2H20 following payment of the deferred liabilities and were not repeated in 1H21). 
  • Capex declined -8% over pcp to $67.6m and was split between stay-in-business capital of $51.8m and development capital of $15.8m. 

Company Description  

Adbri Ltd (ABC) is an Australia listed construction materials and liming producing company. ABC is Australia’s leading (1) lime producer in the minerals processing industry; (2) concrete products producer; and (3) cement and clinker importer. ABC is Australia’s number two cement and clinker supplier to the Australian construction industry and number four concrete and aggregates producer.

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
Global stocks Shares

The share price of Pointsbet has dropped as a result of the FY21 performance.

Investment Thesis

  • U.S. growth opportunity – the U.S. online sports betting market continues to open following the 2018 supreme court ruling which legalise the industry. Market growth estimates forecast the industry to grow to US$51bn by 2033.  
  • Strong management team with a solid track record – the ability to grow market share in a competitive and mature market of Australia gives us some confidence the management team have the right strategy in place to build share in the U.S. 
  • Proprietary technology stack – The speed and useability are key differentiating factors. PBH operates proprietary technology, which it developed inhouse. This means new modifications and updates are easier to implement (i.e., more control) with inhouse tech versus outsourced (i.e., having to go to an external provider each time with an update). 
  • Cross sell opportunities with iGaming – PBH’s recently launched iGaming product (online casino) is already highlighting cross-sell opportunities to its customers.

Key Risks

We see the following key risks to our investment thesis:

  • Rising competitive pressures.
  • Adverse regulatory change in key operating jurisdictions (Australia / U.S.). 
  • Loss of market share in key regions or growth rate fails to meet market expectations. 
  • Higher than expected costs – especially around investment in sales & marketing to drive market share. 
  • Trading on high PE-multiples / valuations means the Company is more prone to share price volatility. 
  • Cyber-attack on PBH’s platform. 

FY21 headline results. 

  • PBH group revenue of $194.7m was up +159% YoY. 
  • Gross profit of $87.6m was up +129% YoY. 
  • PBH made heavy investment in sales and marketing over the year, with S&M expense of $170.7m significantly above the $38.2m in pcp. The Australian segment accounted for $51.4m (higher due to brand campaign with Shaquille O’Neal). However, the U.S. accounted for most of the uplift in marketing spend (total $119.2m) given the increased number of operating jurisdictions. As the footprint in the U.S. continues to expand, management noted the market spend will continue to increase. 
  • At the end of the period, Australia has 196,585 cash active clients (vs. 90,422 in pcp) and the U.S had 159.321 cash active clients (vs 20,939 in pcp). 
  • Group normalised EBITDA for the year was a loss of $156.1m vs loss of $37.6m in the pcp, as PBH continues to invest in the business to scale the U.S. business and invests in its technology stack.
  • Australian Trading segment reported revenue of $150.7m (vs $68.2m in pcp) and EBITDA of $9.2m (vs $6.9m in the pcp). A solid result given the significant increase in marketing spend over the year. 
  • USA segment reported revenue of $42.3m (vs $7.0m in pcp) and EBITDA loss of $149.6m (vs loss of $38.2m in pcp). During the year, PBH operational in six U.S. states: New Jersey, Iowa, Indiana, Illinois, Colorado, and Michigan. 
  • Balance sheet is in a good position to support investment in growth, with pro forma cash balance of $665.2m (post the July 21 capital raising).

Company Description  

PointsBet Holdings Ltd (PBH), founded in 2015, is a corporate bookmaker with operations in Australia and the United States (New Jersey, Iowa, Illinois and Indiana). PointsBet has developed a scalable cloud-based wagering platform which offers customers sports and racing wagering products. PBH’s key products include fixed odds sports, fixed odds racing and PointsBetting.

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
Fixed Income Fixed Income

Suncorp’s stock is in the spotlight following the announcement of a $350 million capital round.

final margin set at 2.90%. The margin is also in line with the recent issuances from Westpac Capital Notes 8 (WBCPK) and Macquarie Capital Notes 3 (MBLPD) (MBPLD are trading largely in line with par value since listing). We note this is a new issuance and therefore has no rollover or reinvestment plan attached to it. The underlying issuer, Suncorp Group, is a strong business and a regular issuer of debt in the market. We would have liked to have seen the final margin at the upper end of the indicative range (3.1% above BBSW). However, the demand for this relatively small issuance ($375m market cap) is also likely to be high given the issuer is someone other than the big 4 banks (although the sector exposure is the same, therefore we are not fully convinced of the diversification benefits here). Our positive view on these is a relative call.

Security Description: 

SUNPI securities are fully paid, subordinated, perpetual, redeemable, convertible, unsecured, non-cumulative, subject to a capital trigger event and non-viability trigger event, listed securities. The securities are scheduled to convert into ordinary shares on 17 Dec 2030 (subject to the conversion conditions being satisfied). 

Issuer Description: 

Suncorp is an ASX-listed company and financial services provider in Australia and New Zealand, and the ultimate parent company of the Suncorp Group, with a market capitalisation of approximately $16 billion as at 27 August 2021. The Suncorp Group offers insurance and banking products and services in Australia and New Zealand. 

KEY RISKS

  • The market price of SUNPI may fluctuate due to various factors that affect financial market conditions. It is possible that SUNPI may trade at a market price below their Issue Price of $100. Interest Rate will fluctuate with changes in the market rate.
  • Significant economic shock to the Australian economy, including a severe and prolonged downturn in the Australian economy. These capital notes are not deposit liabilities or protected accounts.
  • There is a risk that Distributions will not be paid given they are discretionary.
  • Unless exchanged on or before that date, SUNPI are expected to Convert into Ordinary Shares on the Mandatory Conversion Date. However, there is a risk that Conversion will not occur on the Mandatory Conversion Date because the Scheduled Conversion Conditions are not satisfied due to a large fall in the Ordinary Share price relative to the Issue Date VWAP, or if Ordinary Shares cease to be quoted on ASX or have been suspended from trading for a certain period. Mandatory Conversion may therefore not occur when scheduled or at all. The Ordinary Share Price may be affected by transactions affecting the share capital of Suncorp Group, such as rights issues.
  • The market price of SUNPI (and the Ordinary Shares into which they are expected to Convert) may be affected by Suncorp Group’s financial performance and position.

Interest Rate: Margin of 2.9% above the 90day BBSW rate. 

Interest / Distribution Payments: Discretionary, Non-cumulative and subject to following conditions: (1) Distributions will be paid if Suncorp’s capital requirements are sufficient as required by APRA. (2) Distributions will not cause Suncorp to become insolvent. (3) APRA not objecting to distributions being paid. Distributions are expected to be fully franked but not guaranteed.

Mandatory Conversion: On 17 Dec 2030, SUNPI Holders will receive ordinary shares worth $101 per note. Conversion may not occur on 17 Dec June 2030, being the first possible Mandatory Conversion Date, or at all if the Conversion Conditions are not satisfied.  Holders have no right to request that their Notes be Converted, Redeemed or Transferred.  Holders would need to sell their Notes on ASX at the prevailing market price to realise their investment. That price may be less than the Face Value (initially $100 per Note) and there may be no liquid market in the Notes.

Non-Viability Trigger Event:  In case of the event that APRA considers Suncorp non-viable, these notes will be written off (in all or in part) or Converted into Ordinary Shares and Holders will hold Ordinary Shares and rank equally with other holders of Ordinary Shares in a subsequent Winding Up of the Bank. Following a Non-Viability Trigger Event, if Conversion does not occur within five Business Days for any reason, those Capital Notes 4 that are required to be Converted will be Written-Off and Holders will not receive any Ordinary Shares with respect to those Capital Notes 4.

Ranking: In the event of a Winding Up, if the Notes are still on issue and have not been Redeemed or Converted, they will rank ahead of Ordinary Shares, equally among themselves and with all Equal Ranking Capital Securities and behind Senior Creditors (including depositors and holders of Westpac’s senior or less subordinated debt). This means that if there is a shortfall of funds on a Winding Up to pay all amounts ranking senior to, and equally with, the Notes, Holders will lose all or some of their investment.

The above is a brief summary of the terms and risks. Investors should read the PDS for more information.

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
Global stocks Shares

Wesfarmers reported solid revenue in FY 21

Global network and financial technology concept.

Investment Thesis:

  • Ongoing momentum in discretionary spending, fueled by rising property values.
  • Diversified asset base with core assets continuing to grow.
  • Expect improved performance from Target and Industrials business.
  • Continued emphasis on shareholder return, including a high yield.
  • A capable management team.
  • A strong sense of balance allows to seize opportunities as they emerge.
  • Potential  Capital management initiatives.

Key Risks:

  • Due to competitive pressures, margins are eroding.
  • Bunnings earnings have been disappointing.
  • The macro picture is deteriorating, resulting in decreasing retail sales activity and volumes.
  • Metrics on the balance sheet have deteriorated.
  • Adverse movements in AUD/USD.

Key highlights of FY21: Relative to the pcp:

  • During the year WES revenue rose by 10% to $33.9bn relative to previous year.
  • During the year 2020, WES revenue from continuing operation arises broadly from the following segment : 62% from Bunnings,19 % from kmart group, 11% from WesCEF , 6%from Office work  and 2% from Industrial and safety.
  • Bunnings delivered a 15% increase in revenue to $16,871m. Kmart Group revenue increased by 8.3% to $9,982m. Officeworks revenue increased by  8.7% to $3,029m . Wesfarmers Chemicals, Energy &Fertilisers (WesCEF) revenue increased by 2.9% to $2,146m.  Industrial and Safety saw revenue increased by 6.3% to $1,855m
  • NPAT from continuing operations increased by 16.2 % to $2.4 billion (excluding major items).
  • Operating cash flows of $3,383m were 25.6% lower over pcp as strong earnings growth businesses was offset by the normalisation in working capital positions across the retail combined with gross capex of $896m (+3.3% higher over pcp) due to increased investment in data and digital initiatives across all divisions, the conversion of Target stores to Kmart stores, as well as the ongoing development of the Mt Holland lithium project .
  • The company announced a $2.3 billion capital return in the form of a $2 per share payment on top of a final dividend of 90 cents per share, bringing the total payout for the year to $3.78 per share.
  • The Board declared a fully franked final dividend of 90cps, taking the full-year dividend to 178cps (up by 17.1% over pcp) and recommended a return of capital of 200cps, equating to total shareholder return for the year of 378cps.
  • The Company maintained significant balance sheet flexibility, ending the year with a net cash position of $109m.

Company Profile

Wesfarmers Limited (WES) operates convenience stores, home improvement stores, office supply stores, and department stores, among other businesses. Chemicals and fertilisers, industrial and safety items, and coal are all part of the industrial sector of the corporation. Wesfarmers has a workforce of about 220,000 workers.

General Advice Warning

Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.

Categories
Analyst videos Brokers Call Brokers call Expert Insights Fund Manager Interviews Philosophy Stock Talks Technical Picks VidCons Videos

Australian Brokers Call – 03 September 2021

Graphic of investment stock market data analysis business
Brokers-Call-03-September-2021Download